Loading the company…
Loading the company…
In the last ten years FDA made 1 decision for Noah Medical (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2023 (1). The latest was on 2023-03-01.
| Family | Decisions on record |
|---|---|
| Bronchoscopy & lung nodule | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2023-03-01 | 510(k) | K223144 | Galaxy System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Noah Medical.
In 2025, Noah Medical reported engagement with 308 surgeons and other clinicians in the states MedaRep covers, worth $971K in consulting, speaking, meals and travel for its device products, the most in Virginia ($199K to 27). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: Virginia ($199K, 27 engaged), Ohio ($155K, 27 engaged), Illinois ($149K, 10 engaged), California ($115K, 24 engaged), South Carolina ($100K, 13 engaged).